Table 5 Framingham Heart Study Data (N = 2262)
From: Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study
Characteristics | Exam 2 | Exam 3 | Exam 4 | Exam 5 | Exam 6 | Exam 7 |
|---|---|---|---|---|---|---|
Sample Size – Na | 2262 | 2211 | 2173 | 2118 | 2056 | 1995 |
Longitudinal Data – Years | 1979–1983 | 1983–1987 | 1987–1991 | 1991–1995 | 1995–1998 | 1998–2001 |
Age (Years) | 43.32 (9.58) | 47.69 (9.60) | 51.15 (9.60) | 54.80 (9.60) | 58.87 (9.54) | 61.78 (9.45) |
Triglycerides (mg/dL) | 100.49 (88.77) | 118.80 (123.59) | 124.15 (110.18) | 154.47 (133.08) | 153.08 (114.92) | 158.70 (112.49) |
Survival Time in Years | 4.33 (0.60) | 3.43 (0.46) | 3.61 (0.46) | 4.01 (0.60) | 2.87 (0.86) | 6.00 (1.62) |
Cumulative Event Rate (%) | 0.44% | 0.88% | 1.46% | 2.08% | 2.39% | 3.71% |
Sex (% Female) | 51.19% | |||||